Achieve Reports Financial Results for First Quarter 2020 and Provides Update on Cytisinicline Development Program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to Achieve Reports Financial Results for First Quarter 2020 and Provides Update on Cytisinicline Development Program

Achieve Life Sciences (ACHV) Tops Q1 EPS by 1c

May 14, 2020 7:34 AM EDT

Achieve Life Sciences (NASDAQ: ACHV) reported Q1 EPS of ($0.11), $0.01 better than the analyst estimate of ($0.12).

Recent Highlights

Submitted required non-clinical supportive data for longer cytisinicline treatment to the U.S. Food & Drug Administration (FDA) in preparation for Phase 3 cytisinicline ORCA-2 trial initiationClosed... More